BioStem Technologies, Inc.
OTC: BSEM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jason Matuszewski
- Headquarters
- Fort Lauderdale, United States
- IPO year
- 2015
- Market cap
- $66.1M
- Website
- https://biostemtechnologies.com
Loading BSEM…
Loading profile data…Frequently asked questions about BSEM
What does BioStem Technologies, Inc. (BSEM) do?
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allogra...
Where does BSEM trade?
BioStem Technologies, Inc. (BSEM) trades on the Other OTC.
What sector is BSEM in?
BioStem Technologies, Inc. (BSEM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BioStem Technologies, Inc.?
Jason Matuszewski is the chief executive officer of BioStem Technologies, Inc. (BSEM).
Where is BioStem Technologies, Inc. headquartered?
BioStem Technologies, Inc. is headquartered in United States.
Does BSEM pay a dividend?
BioStem Technologies, Inc. (BSEM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BSEM go public?
BioStem Technologies, Inc. (BSEM) completed its initial public offering in 2015.